Wellcome Trust Sanger Institute Apr 23 2026 It may be possible to identify which pre-cancerous cells will develop into a rare type of blood cancer, due to new research showing that a single genetic change drives myeloid leukemia in children with Down syndrome. An international team, including those at the Wellcome Sanger Institute, Great Ormond Street Hospital, Goethe University Frankfurt, Cambridge University Hospitals, and their collaborators, investigated the differences between cancer cells